Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Invested Capital (2016 - 2025)

Firefly Neuroscience has reported Invested Capital over the past 15 years, most recently at $7.6 million for Q4 2025.

  • Quarterly results put Invested Capital at $7.6 million for Q4 2025, up 2294.04% from a year ago — trailing twelve months through Dec 2025 was $7.6 million (up 2294.04% YoY), and the annual figure for FY2025 was $7.6 million, up 2294.04%.
  • Invested Capital for Q4 2025 was $7.6 million at Firefly Neuroscience, down from $9.7 million in the prior quarter.
  • Over the last five years, Invested Capital for AIFF hit a ceiling of $17.4 million in Q4 2021 and a floor of -$2.8 million in Q3 2024.
  • Median Invested Capital over the past 5 years was $3.3 million (2021), compared with a mean of $5.3 million.
  • Biggest five-year swings in Invested Capital: tumbled 425.57% in 2024 and later skyrocketed 2294.04% in 2025.
  • Firefly Neuroscience's Invested Capital stood at $17.4 million in 2021, then plummeted by 110.33% to -$1.8 million in 2022, then soared by 106.05% to $109000.0 in 2023, then skyrocketed by 192.66% to $319000.0 in 2024, then skyrocketed by 2294.04% to $7.6 million in 2025.
  • The last three reported values for Invested Capital were $7.6 million (Q4 2025), $9.7 million (Q3 2025), and $12.6 million (Q2 2025) per Business Quant data.